Table 2 Detailed patient characteristics for each propensity score quintile
Propensity-Score Quintile 1 n (%) or Median [Quartile 1 - Quartile 3] N = 94 | Propensity-Score Quintile 2 n (%) or Median [Quartile 1 - Quartile 3] N = 93 | Propensity-Score Quintile 3 n (%) or Median [Quartile 1 - Quartile 3] N = 93 | Propensity-Score Quintile 4 n (%) or Median [Quartile 1 - Quartile 3] N = 93 | Propensity-Score Quintile 5 n (%) or Median [Quartile 1 - Quartile 3] N = 93 | P-value | |
|---|---|---|---|---|---|---|
Renal improvement | 34 (36.2) | 42 (45.2) | 52 (55.9) | 59 (63.4) | 68 (73.1) | < 0.001 |
Age (years) | 76 [73–79] | 81 [77–85] | 82 [79–86] | 83 [80–87] | 86 [81–90] | < 0.001 |
Males | 80 (85.1) | 46 (49.5) | 32 (34.4) | 20 (21.5) | 22 (23.7) | < 0.001 |
Body-Mass-Index (kg/m2) | 28.34 [25.61–32.25] | 26.67 [24.14–30.48] | 27.34 [23.83–29.59] | 25.15 [22.95–29.35] | 23.6 [21.69–26.63] | < 0.001 |
LVEF < 35% | 13 (13.8) | 7 (7.5) | 10 (10.8) | 9 (9.7) | 10 (10.8) | 0.31 |
NYHA class III or IV | 40 (42.6) | 51 (54.8) | 64 (68.8) | 85 (91.4) | 88 (94.6) | < 0.001 |
Comorbidities | ||||||
Coronary artery disease | 75 (79.8) | 65 (69.9) | 65 (69.9) | 61 (65.6) | 61 (65.6) | 0.20 |
Atrial fibrillation | 35 (37.2) | 27 (29.0) | 40 (43.0) | 50 (53.8) | 52 (55.9) | 0.001 |
Hypertension | 86 (91.5) | 87 (93.5) | 80 (86) | 85 (91.4) | 84 (90.3) | 0.49 |
Dyslipidemia | 56 (59.6) | 56 (60.2) | 44 (47.3) | 40 (43.0) | 32 (34.4) | 0.001 |
Cerebrovascular disease | 15 (16.0) | 22 (23.7) | 20 (21.5) | 12 (12.9) | 15 (16.1) | 0.30 |
Diabetes mellitus | 39 (41.5) | 26 (28.0) | 38 (40.9) | 21 (22.6) | 17 (18.3) | 0.001 |
Peripheral artery disease | 17 (18.1) | 13 (14.0) | 12 (12.9) | 12 (12.9) | 9 (9.7) | 0.57 |
COPD | 14 (14.9) | 6 (6.5) | 10 (10.8) | 18 (19.4) | 12 (12.9) | 0.11 |
Dialysis | 1 (1.1) | 0 (0.0) | 1 (1.1) | 1 (1.1) | 2 (2.2) | 0.73 |
Logistic EuroSCORE | 12.8 [7.9–21.7] | 14.28 [8.37–24.2] | 12.91 [9.25–23.52] | 15.08 [10.3–25.18] | 19.67 [14.12–27.85] | < 0.001 |
EuroSCORE II | 4.1 [1.95–7.63] | 3.54 [2.38–7.07] | 3.86 [2.67–7.06] | 4.29 [2.94–7.01] | 5.48 [3.74–8.02] | 0.001 |
STS score | 3.25 [1.99–5.54] | 3.73 [2.4–6.07] | 4.23 [3–5.82] | 4.73 [3.27–5.93] | 6.29 [4.31–8.46] | < 0.001 |
NT-proBNP (ng/l) | 1097 [474–2194] | 1016 [541–2500] | 1130 [693–3092] | 2184 [907–3802] | 7042 [2969–12,890] | < 0.001 |
hsTNT (pg/ml) | 24.7 [15.25–43.83] | 23.3 [14.05–37] | 21.8 [13.45–39.4] | 23.3 [16.45–44.1] | 38 [23.7–72.65] | < 0.001 |
eGFR (ml/min/1.73m2) | 73 [52–98] | 64 [42–85] | 52 [42–69] | 50 [35–66] | 36 [26–49] | < 0.001 |
Creatinine (μmol/l) | 98.24 [76.59–117.62] | 91.51 [75.62–119.5] | 93.81 [77–117.41] | 98.24 [77–120.98] | 120 [95.41–165.94] | < 0.001 |
Urea (mmol/l) | 6.66 [5.38–9.49] | 6.5 [5.2–10.05] | 7.33 [5.33–9.68] | 7.16 [5.7–10.05] | 9.82 [6.23–13.64] | < 0.001 |
CRP (mg/l) | 3.2 [1.2–7.7] | 2.3 [1.1–5.6] | 3.1 [1.5–8.3] | 4.9 [2.05–12.1] | 6.4 [1.8–24.5] | < 0.001 |